Showing posts with label Cholesterol. Show all posts
Showing posts with label Cholesterol. Show all posts

Tuesday, January 29, 2019

Ongoing saga of contaminated sartans




·         In the ongoing saga of contaminated sartans, Torrent Pharmaceuticals Limited has expanded its voluntary recall of losartan potassium and hydrochlorothiazide combination tablets to include six more lots, for a total of 16 lots of losartan-containing medicines recalled since December. The recall, to the consumer level, stems from the detection of the probable carcinogen N-nitrosodiethylamine (NDEA) in the active pharmaceutical ingredient (losartan) manufactured by Hetero Labs Limited. The recalled lots have NDEA levels above acceptable daily intake levels released by the US Food and Drug Administration (FDA).

·         Card diversions have beneficial effects on emotional wellness. In 2014, the University of Wisconsin-Madison completed an examination that discovered playing card diversions can enable individuals to remain rationally sharp in maturity, as detailed here and by Alzheimer’s Research UK. 90+ recommends that individuals who invest more energy taking part in mental exercises like card amusements might be at less danger of experiencing dementia. Other research like this New England Journal of Medicine ponder likewise proposes that relaxation exercises are related with a diminished danger of dementia. These reports unmistakably demonstrate that playing cards gives certifiable emotional wellness benefits, and particularly among the old.

·         Association between cholesterol levels and sepsis: Although low levels of low-density-lipoprotein cholesterol (LDL-C) seem to be associated with an increased risk for sepsis and admission to the intensive care unit (ICU) in patients hospitalized for infection, the relation appears to be connected to comorbidities rather than LDL-C levels per se, suggests a new study published online Jan. 18, 2019 in JAMA Network Open.

·         Patients with NAFLD are at an increased risk for CVD compared to matched controls, but histological parameters do not seem to independently predict this risk (Liver International. 2018;39(1):197-204).

·         Need for vitamin and nutritional supplements: Most people do not need to take vitamins or nutritional supplements because they can get all the nutrients they need by eating a healthy diet, as per a new patient resource published Jan. 7, 2019 in JAMA Internal Medicine. But there are more than 90,000 supplements on the US market that include a wide range of vitamins, minerals and chemicals.

Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA


Monday, July 21, 2014

Seven Behaviors Cut Heart Deaths

Seven heart–healthy behaviors can reduce the risk of death from cardiovascular disease. In a prospective study, by Enrique Artero, PhD, of the University of South Carolina, and colleagues and published in the October issue of the Mayo Clinic Proceedings, those who met 3–4 of the American Heart Association’s ‘Simple Seven’ heart–health criteria had a 55% lower risk of cardiovascular mortality than those who met no more than two of those practices over 11 years.
Four core behaviors
  1. No smoking
  2. Normal body mass index
  3. Engaging in physical activity
  4. Eating healthfully
Three parameters
  1. Cholesterol lower than 200 mg/dL
  2. Blood pressure lower than 120/80 mm Hg
  3. Not having diabetes

Wednesday, January 16, 2013

A daylong conference on 20th January


eMedinewS and Heart Care Foundation of India will be organizing a daylong conference on 20th January, 2013 at Maulana Azad Medical College and will be attended by over 1000 doctors. The conference will revisit the happenings of the year 2012.

Addressing a press conference here Padma Shri & Dr. BC Roy National Awardee, Dr. KK Aggarwal, Group Editor-in-Chief eMedinewS and President Heart Care Foundation of India, and Dr Ganesh Mani, Dr Ashish Jain, Dr. Vivek Bhatia, Dr. Praveen Bhatia, Dr Jugal Mishra, Dr. N.K.Bhatia, Dr. Neeraj Jain, Dr Kailash Singla and Dr. Praveen Chandra, in a joint statement said that a lot has changed in the last one year. Following were a few of the new advancements:

1. The new mantra for Cardiopulmonary Resuscitation (CPR10) – Over 25000 people in the city of Delhi alone have been trained in CPR10 to revive people out of sudden death. The mantra created by Dr. KK Aggarwal simplifies the course of action to be taken by people – “within 10 minutes of death (earlier the better), at least for the next 10 minutes (longer the better – upto 25 minutes), compress the centre of the chest of the victim effectively and continuously with a speed of 10x10 i.e. 100 per minutes”.
2. For patients whose blood pressure is not getting under control, new treatment is denervation of the nerves connected to the kidney.
3. For suspected rheumatic heart diseases, echo screening and not clinical screening is the answer.
4. Bypass surgery is better than drug quoted stents in patients with diabetes.
5. Pre-exposure prophylaxes with tenofvir and emtricitadine is now an established way of preventing HIV in high risk individuals.
6. New guidelines suggest that all patients of HIV+ should be treated regardless of CD4 T cells count.
7. Bacterial nasal sinusitis needs to be treated by anti-biotic and should be differentiated from viral nasal sinusitis.
8. In patients over the age of 70 years being treated with enema for constipation, one should use warm water enema rather than sodium phosphate enema.
9. In women of 65 years of age and older with a normal or slightly low bone mass at baseline measurement and with no risk factors of accelerated bone loss, follow-up bone densitometry should be done between 10-15 years.
10. Patients with high cholesterol on statin no more require monitoring of liver functions. They should be done only at baseline and not thereafter
11. Patients of depression on citalopriam should not be given a dose more than 40 mg and in 60+, it should not be more than 20mg.
12. Bio-absorbable polymers stent are now available in India.
13. Without surgery aortic valve replacement via catheter has now started in India.
14. Small intestinal transplant has been added to the list of transplant in the country.
15. Recently, a patient from Delhi who was brain dead donated his organs to 37 people.
16. A circular from Ministry of Health and Family Welfare has clarified that under the PNDT Act, medical practitioners with post graduation in gynecology and obstetrics are qualified to do obstetric ultrasound.
17. Suspect bacterial infection if:
a. Persistent symptoms or signs lasting more than 10 days with no improvement.
b. Onset with fever of more than 102 degree and purulent nasal discharge lasting three consecutive days.
c. Onset with worsening symptoms following a viral URI lasting 5-6 days which was initially improving.

Mr Gursharan Singh former Indian Cricketer was the special guest of the day.

The conference will be followed by ‘Doctor of the year’ awards and cultural evening.

Saturday, August 20, 2011

HCFI Update: Janmashtami is not about eating butter and butter oils.


Janmashtami is a festival to spread love and not eating butter, butter oils and trans fats said Padma Shri and Dr B C Roy National Awardee Dr KK Aggarwal President Heart Care Foundation of India and MTNL Perfect Health Mela.  A 1% rise in total and or bad LDL cholesterol increase the chances of heart attack by 2%; also, a 1% reduction in the good HDL cholesterol increases the chances of heart attack by 3%.

Heart patients, diabetics and obese people should not eat butter this Janmashtami, a festival to spread love and happiness and not eating butter, said Padma Shri and Dr B C Roy National Awardee Dr KK Aggarwal President Heart Care Foundation of India and MTNL Perfect Health Mela.

One teaspoonful of butter contains 25 mg cholesterol. Butter and butter oil contain saturated fats which can be harmful to the heart.

Any fat of plant in origin has no cholesterol. Only foods that are of animal origin contain cholesterol. Butter and butter oil being animal in origin are high in cholesterol and saturated fats.

Fats that are solid at room temperature are saturated and those that are liquid at room temperature are unsaturated. It is the saturated and the trans saturated fats which increase the bad LDL cholesterol. A 1% increase in total and or bad LDL cholesterol increase the chances of heart attack by 2%.

Trans fat is just as bad. Hydrogenated oils available as vanaspati contain trans fats and are worse than butter. They increase the bad LDL cholesterol and reduce the good HDL cholesterol. A 1% reduction in good HDL cholesterol increases the chances of heart attack by 3%.

Chocolate is equally bad as it contains refined sugar and can increase insulin resistance and makes one more prone to develop diabetes and abdominal obesity.

Thursday, August 11, 2011

#AskDrKK: What are the cholesterol abnormalities seen in heart diseases in the young?


#DrKKAnswers: Younger people have lower good HDL cholesterol and higher Serum Triglyceride levels. The average HDL cholesterol in young heart disease patients is 35 and average triglyceride is 239 mg/dL. In heart patients above the age of 40 years , the average HDL cholesterol is 43 and average triglyceride is 86 mg/dL. 

Monday, July 25, 2011

Dr.KK’s tip on Desi Ghee Vs Vanaspati Ghee


While Desi Ghee (butter oil) increases bad LDL cholesterol it does not affect the levels of good HDL cholesterol.
Vanaspati Ghee increases bad LDL cholesterol and reduces good HDL cholesterol. Vanaspati, therefore, is more harmful than Desi Ghee.

Saturday, July 23, 2011

Dr K K Answers: Can garlic lower cholesterol?

In ayurveda Garlic has been advocated as a method to lower serum cholesterol concentrations.

However a large randomized trial compared three different garlic preparations (raw, powdered, and aged garlic extracts, dose one 4 gram clove) and placebo in 192 adults with LDL bad cholesterol 130-190 mg/dL.

Patients were treated six days per week for six months, and none of the preparations of garlic had a significant effect on LDL-C or other lipid levels

Reference
Arch Intern Med 2007; 167:346

Sunday, May 29, 2011

NIH stops clinical trial on combination cholesterol treatment

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended–release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular events, including heart attacks and stroke.

Participants were selected for AIM–HIGH because they were at risk for cardiovascular events despite well–controlled low–density lipoprotein (LDL or bad cholesterol). Their increased risk was due to a history of cardiovascular disease and a combination of low high–density lipoprotein (HDL or good cholesterol) and high triglycerides, another form of fat in the blood. Low HDL and elevated triglycerides are associated with an increased risk of cardiovascular events. While lowering LDL decreases the risk of cardiovascular events, it has not been shown that raising HDL similarly reduces the risk of cardiovascular events. During the study’s 32 months of follow–up, participants who took high dose, extended–release niacin and statin treatment had increased HDL cholesterol and lowered triglyceride levels compared to participants who took a statin alone. However, the combination treatment did not reduce fatal or non–fatal heart attacks, strokes, hospitalizations for acute coronary syndrome, or revascularization procedures to improve blood flow in the arteries of the heart and brain.

The AIM–HIGH trial, which stands for Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health, enrolled 3,414 participants in the United States and Canada with a history of cardiovascular disease who were taking a statin drug to keep their LDL cholesterol low. Study participants also had low HDL cholesterol and high triglycerides, which meant that they were at significant risk of experiencing future cardiovascular events. Niacin, also known as Vitamin B3, has long been known to raise HDL and lower triglycerides. Eligible participants were randomly assigned to either high dose, extended–release niacin (Niaspan) in gradually increasing doses up to 2,000 mg per day (1,718 people) or a placebo treatment (1,696 people). All participants were prescribed simvastatin (Zocor), and 515 participants were given a second LDL cholesterol–lowering drug, ezetimibe (Zetia), in order to maintain LDL cholesterol levels at the target range between 40–80 mg/dL.
Researchers began recruiting participants in early 2006. The study was scheduled to finish in 2012. The average age of the participants was 64 years. Pre-existing medical conditions included coronary artery disease (92 percent); metabolic syndrome, which is a cluster of risk factors for heart disease (81 percent); high blood pressure (71 percent); and diabetes (34 percent). More than half of participants reported having a heart attack prior to entering the study.

The rationale for the AIM–HIGH study was based in part on a large number of observational studies that consistently showed that low HDL cholesterol increases the risk of cardiovascular events in men and women, independent of high LDL cholesterol. In addition, previous small clinical studies showed that relatively high residual cardiovascular risk exists among patients with cardiovascular disease, low HDL cholesterol, and high triglycerides despite intensive management of LDL cholesterol.